Professor Thomas Helleday at Karolinska Institutet and Biovica in research collaboration to evaluate new promising cancer treatments

The laboratory headed by Thomas Helleday at Karolinska Institutet, (Stockholm) and Biovica (Uppsala) have entered a research collaboration to improve evaluation and development of new, promising cancer therapies. The aim of the collaboration project is to assess whether information gathered with Biovicas DiviTum™ assay has the potential to provide early evidence of efficacy regarding the [...]

2017-01-03T10:51:07+00:00 January 29th, 2016 11:00|Regulatory|